Is the Optimal Dose of Heart Failure Medical Therapy Different in Women and Men?
European Journal of Heart Failure · 01.08.2024 · 26 (8) · 1699-1702
DOI: 10.1002/ejhf.3320 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Heart Failure, online erschienen am 27.05.2024. Verfasst von Maria A Pabon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- National Heart Centre Singapore, Duke-National University of Singapore, Singapore, Singapore.
ORCID-Profile: Maria A Pabon
Zitieren
APA
Pabon, M. A., Vaduganathan, M., & Lam, C. S. P. (2024). Is the Optimal Dose of Heart Failure Medical Therapy Different in Women and Men?. European Journal of Heart Failure, 26(8), 1699-1702. https://doi.org/10.1002/ejhf.3320
Vancouver
Pabon MA, Vaduganathan M, Lam CSP. Is the Optimal Dose of Heart Failure Medical Therapy Different in Women and Men?. European Journal of Heart Failure. 2024;26(8):1699-1702. doi:10.1002/ejhf.3320
BibTeX
@article{Pabon2024,
author = {Pabon, Maria A and Vaduganathan, Muthiah and Lam, Carolyn S P},
title = {Is the Optimal Dose of Heart Failure Medical Therapy Different in Women and Men?},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {8},
pages = {1699--1702},
doi = {10.1002/ejhf.3320}
}
EUVIMED